The samples of the vaccine, developed by China’s Sinovac Biotech, which were brought on Dec. 30, 2020, are tested in accordance with the routine quality control processes applied all over the world, Health Ministry said in a statement.
Analyses are underway to check the expected quality, effectiveness, and reliability of the vaccine when it is stored and applied under conditions defined by the company throughout its shelf life, it added.
If it passes at least 14-day-long tests, the vaccine will be put into use following an “Emergency Use Approval” by Turkey Pharmaceuticals and Medical Devices Institution, according to the ministry.
The institution’s labs, known as the National Control Laboratories, are recognized and accredited by international equivalent institutions and organizations.
All vaccines listed in the ministry’s vaccination program, along with medical biological products, medicines, enteral nutrition products and medical foods, medical devices, biocidal products and cosmetics, are tested in these labs.
Healthcare staff and nursing homes will be the first to receive the vaccines, according to Health Minister Fahrettin Koca.
The vaccine will be applied by the Health Ministry’s coronavirus vaccine application units which will be established in family health centers, private and university hospitals, according to the Health Services Directorate.
Those who want be vaccinated will apply to these units by appointment.
Turkey on Monday confirmed 13,695 new cases, including 1,508 symptomatic patients, raising the tally of infections to over 2.25 million.
The country’s coronavirus death toll currently stands at 21,685.
